During IBD, immune cells infiltrate the intestinal mucosa and secrete pro-inflammatory cytokines (e.g., TNF-α, IL-1β) and growth factors (e.g., VEGF, FGF), which directly activate endothelial cells (ECs). Here, VEGFA is linked to inflammatory bowel disease.